162 related articles for article (PubMed ID: 33494691)
1. Novel Strategy in Breast Cancer Therapy: Revealing The Bright Side of Ginsenosides.
Hashemi F; Zarrabi A; Zabolian A; Saleki H; Farahani MV; Sharifzadeh SO; Ghahremaniyeh Z; Bejandi AK; Hushmandi K; Ashrafizadeh M; Khan H
Curr Mol Pharmacol; 2021; 14(6):1093-1111. PubMed ID: 33494691
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer.
Guo YH; Kuruganti R; Gao Y
Curr Top Med Chem; 2019; 19(25):2334-2347. PubMed ID: 31648643
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of ginsenosides on breast cancer growth and metastasis.
Jin Y; Huynh DTN; Nguyen TLL; Jeon H; Heo KS
Arch Pharm Res; 2020 Aug; 43(8):773-787. PubMed ID: 32839835
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells.
Kang JH; Song KH; Woo JK; Park MH; Rhee MH; Choi C; Oh SH
Plant Foods Hum Nutr; 2011 Sep; 66(3):298-305. PubMed ID: 21748437
[TBL] [Abstract][Full Text] [Related]
7. Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease.
Wang L; Zhang Y; Song Z; Liu Q; Fan D; Song X
Food Funct; 2023 Oct; 14(20):9137-9166. PubMed ID: 37801293
[TBL] [Abstract][Full Text] [Related]
8. The effects of Ginsenosides on PI3K/AKT signaling pathway.
Ghafouri-Fard S; Balaei N; Shoorei H; Hasan SMF; Hussen BM; Talebi SF; Taheri M; Ayatollahi SA
Mol Biol Rep; 2022 Jul; 49(7):6701-6716. PubMed ID: 35220526
[TBL] [Abstract][Full Text] [Related]
9. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
Liu Y; Fan D
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
[TBL] [Abstract][Full Text] [Related]
10. Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma.
Zhou N; Mao F; Cheng S
Biomed Res Int; 2023; 2023():7214037. PubMed ID: 38027042
[TBL] [Abstract][Full Text] [Related]
11. Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2.
Wang W; Zhang X; Qin JJ; Voruganti S; Nag SA; Wang MH; Wang H; Zhang R
PLoS One; 2012; 7(7):e41586. PubMed ID: 22911819
[TBL] [Abstract][Full Text] [Related]
12. Carbon nanotubes as carriers of Panax ginseng metabolites and enhancers of ginsenosides Rb1 and Rg1 anti-cancer activity.
Lahiani MH; Eassa S; Parnell C; Nima Z; Ghosh A; Biris AS; Khodakovskaya MV
Nanotechnology; 2017 Jan; 28(1):015101. PubMed ID: 27893436
[TBL] [Abstract][Full Text] [Related]
13. Ginsenosides are Promising Medicine for Tumor and Inflammation: A Review.
Li J; Li F; Jin D
Am J Chin Med; 2023; 51(4):883-908. PubMed ID: 37060192
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].
Cao M; Yu HS; Song XB; Ma BP
Yao Xue Xue Bao; 2012 Jul; 47(7):836-43. PubMed ID: 22993845
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells.
Shi X; Yang J; Wei G
Mol Med Rep; 2018 Mar; 17(3):4811-4816. PubMed ID: 29363731
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells.
Lee JI; Ha YW; Choi TW; Kim HJ; Kim SM; Jang HJ; Choi JH; Choi MH; Chung BC; Sethi G; Kim SH; Ahn KS; Choi SH; Shim BS; Ahn KS
Planta Med; 2011 Jan; 77(2):133-40. PubMed ID: 20669086
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer.
Fan M; Shan M; Lan X; Fang X; Song D; Luo H; Wu D
Front Pharmacol; 2022; 13():1033017. PubMed ID: 36278171
[TBL] [Abstract][Full Text] [Related]
19. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
20. A review of anti-tumour effects of ginsenoside in gastrointestinal cancer.
Xu J; Pan Y; Liu Y; Na S; Zhou H; Li L; Chen F; Song H
J Pharm Pharmacol; 2021 Sep; 73(10):1292-1301. PubMed ID: 33836068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
